These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 27139504

  • 1. Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.
    Ye RR, Tan CP, Ji LN, Mao ZW.
    Dalton Trans; 2016 Aug 16; 45(33):13042-51. PubMed ID: 27139504
    [Abstract] [Full Text] [Related]

  • 2. Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents.
    Li Y, Tan CP, Zhang W, He L, Ji LN, Mao ZW.
    Biomaterials; 2015 Jan 16; 39():95-104. PubMed ID: 25477176
    [Abstract] [Full Text] [Related]

  • 3. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y, Liu B, Xu CX, He L, Wan YC, Ji LN, Mao ZW.
    J Biol Inorg Chem; 2020 Jun 16; 25(4):597-607. PubMed ID: 32232583
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo.
    He L, Wang KN, Zheng Y, Cao JJ, Zhang MF, Tan CP, Ji LN, Mao ZW.
    Dalton Trans; 2018 May 22; 47(20):6942-6953. PubMed ID: 29721561
    [Abstract] [Full Text] [Related]

  • 6. Valproic Acid-Functionalized Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
    Ye RR, Cao JJ, Tan CP, Ji LN, Mao ZW.
    Chemistry; 2017 Oct 26; 23(60):15166-15176. PubMed ID: 28833658
    [Abstract] [Full Text] [Related]

  • 7. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
    Song XD, Kong X, He SF, Chen JX, Sun J, Chen BB, Zhao JW, Mao ZW.
    Eur J Med Chem; 2017 Sep 29; 138():246-254. PubMed ID: 28668477
    [Abstract] [Full Text] [Related]

  • 8. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
    Zhang WY, Yi QY, Wang YJ, Du F, He M, Tang B, Wan D, Liu YJ, Huang HL.
    Eur J Med Chem; 2018 May 10; 151():568-584. PubMed ID: 29656200
    [Abstract] [Full Text] [Related]

  • 9. Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.
    Li Y, Liu B, Lu XR, Li MF, Ji LN, Mao ZW.
    Dalton Trans; 2017 Aug 29; 46(34):11363-11371. PubMed ID: 28812748
    [Abstract] [Full Text] [Related]

  • 10. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J, Tian Z, Xu Z, Zhang S, Feng Y, Zhang L, Liu Z.
    Dalton Trans; 2018 Nov 13; 47(44):15772-15782. PubMed ID: 30357192
    [Abstract] [Full Text] [Related]

  • 11. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y, Guo L, Tian Z, Gong Y, Zheng H, Zhang S, Xu Z, Ge X, Liu Z.
    Inorg Chem; 2018 Sep 04; 57(17):11087-11098. PubMed ID: 30133276
    [Abstract] [Full Text] [Related]

  • 12. Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
    Wang FX, Chen MH, Hu XY, Ye RR, Tan CP, Ji LN, Mao ZW.
    Sci Rep; 2016 Dec 13; 6():38954. PubMed ID: 27958338
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes.
    Li Y, Wang KN, He L, Ji LN, Mao ZW.
    J Inorg Biochem; 2020 Apr 13; 205():110976. PubMed ID: 31926377
    [Abstract] [Full Text] [Related]

  • 14. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
    Zhang H, Tian L, Xiao R, Zhou Y, Zhang Y, Hao J, Liu Y, Wang J.
    Bioorg Chem; 2021 Oct 13; 115():105290. PubMed ID: 34426145
    [Abstract] [Full Text] [Related]

  • 15. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis.
    Chen BB, Pan NL, Liao JX, Huang MY, Jiang DC, Wang JJ, Qiu HJ, Chen JX, Li L, Sun J.
    J Inorg Biochem; 2021 Jun 13; 219():111450. PubMed ID: 33826973
    [Abstract] [Full Text] [Related]

  • 16. Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics.
    Laws K, Eskandari A, Lu C, Suntharalingam K.
    Chemistry; 2018 Oct 12; 24(57):15205-15210. PubMed ID: 30052298
    [Abstract] [Full Text] [Related]

  • 17. Iminoamido chelated iridium(III) and ruthenium(II) anticancer complexes with mitochondria-targeting ability and potential to overcome cisplatin resistance.
    Guo L, Li P, Jing Z, Gong Y, Lai K, Fu H, Dong H, Yang Z, Liu Z.
    J Inorg Biochem; 2024 Sep 12; 258():112631. PubMed ID: 38843774
    [Abstract] [Full Text] [Related]

  • 18. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
    Ma W, Zhang S, Tian Z, Xu Z, Zhang Y, Xia X, Chen X, Liu Z.
    Eur J Med Chem; 2019 Nov 01; 181():111599. PubMed ID: 31408807
    [Abstract] [Full Text] [Related]

  • 19. Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents.
    Wu Y, Liu J, Shao M, Zhang P, Song S, Yang G, Liu X, Liu Z.
    J Inorg Biochem; 2022 Aug 01; 233():111855. PubMed ID: 35576884
    [Abstract] [Full Text] [Related]

  • 20. Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy.
    Ye RR, Tan CP, He L, Chen MH, Ji LN, Mao ZW.
    Chem Commun (Camb); 2014 Sep 28; 50(75):10945-8. PubMed ID: 25096019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.